#Sweden #Gothenburg #revenue growth #Zinzino #financial report

Zinzino AB Reports Remarkable Revenue Growth

On December 3, 2025, Zinzino AB unveiled its preliminary sales report, highlighting a striking increase in revenue of 45% compared to the previous year. This announcement has generated significant interest within the investment community, as the company navigates a rapidly changing market landscape.

Overview of Financial Performance

In November 2025, Zinzino's total revenue climbed to SEK 375.0 million, a sharp rise from SEK 251.8 million the same month a year ago. This translates to a remarkable 49% increase in sales across Zinzino’s various markets. When incorporating Faun Pharma’s performance, Zinzino's overall revenue surged by 45% resulting in a total of SEK 379.3 million, compared to SEK 261.9 million for November 2024.

Additionally, the accumulated revenue for the period from January to November 2025 soared by 54%, reaching SEK 3,007.5 million, up from SEK 1,955.1 million the previous year. This consistent upward trend has solidified Zinzino's position in the market and showcases the company's effective strategies in expanding its customer base while enhancing sales performance.

Revenue Breakdown by Region

A more detailed look at Zinzino's financial performance by region reveals distinct patterns in sales growth:

• - The Nordics: A modest increase of 2% was reported, leading to revenues of SEK 29.7 million. Year-to-date (YTD), sales in this region rose by 11% to SEK 301.0 million.
• - Central Europe: This region saw an impressive growth of 90%, accumulating revenues of SEK 133.9 million, with YTD figures soaring 72% to SEK 892.2 million.
• - Eastern Europe: Sales remained relatively stable with negligible changes, totaling SEK 51.5 million.
• - South West Europe: A significant growth of 30% pushed revenues up to SEK 58.7 million, YTD sales reflecting a 48% increase.
• - The Baltics: Revenue grew by 7%, reaching SEK 17.3 million, a sign of steady growth in this market.
• - North America: Notably, this region experienced a staggering 125% growth, bringing revenue to SEK 58.1 million, illustrating Zinzino's successful expansion strategy.
• - Asia-Pacific: This region also performed exceptionally well, with a remarkable growth rate of 107%, totaling SEK 23.0 million.
• - Africa: A modest increase of 12% was registered, with revenues amounting to SEK 2.8 million.

The strategic targeting of these key regions has proved fruitful, reflecting Zinzino's ability to adapt and thrive in various international markets.

Emerging Trends and Future Outlook

The success of Zinzino AB over the past year can be attributed to several factors. Strong product innovation, an emphasis on consumer health, and effective marketing campaigns have resonated well with consumers. Additionally, expanding distribution channels facilitated access to a broader audience, significantly enhancing sales potential.

As part of their ongoing growth strategy, Zinzino's management emphasizes the importance of continued investment in research and development to introduce new products that meet changing consumer demands. The company remains optimistic about maintaining its growth trajectory into 2026 and beyond.

In summary, Zinzino AB's impressive revenue growth not only underscores the company’s market strength but also indicates a promising year ahead as they continue to innovate and expand their presence in the global market. Investors and analysts alike will be watching closely to see how Zinzino maintains this momentum in the coming months.